secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2026-04-23T23:59:59+00:00
Accession:  0001193125-26-173770
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin receives French FDI clearance for Amicus merger; closing expected April 27, 2026
--------------------------------------------------------------------------------

- French Ministry of Economics and Finance granted FDI clearance for merger with Amicus on April 23, 2026.
- Receipt of clearance satisfies final condition to the merger other than closing conditions.
- Merger expected to close on April 27, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000119312526173770/0001193125-26-173770-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000119312526173770/d139584d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-173770

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer